Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/29/26 16:04 | 5/28/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Fromkin Andrew J. | NC | D | 1 | S.d | -7,438 | 33.51 | 0 | -222 | 74 | D | ||||||||||||||||
5/22/26 16:03 | 4/8/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Gloria Melanie | NC | O | COO | 2 | S | -318 | 26.83 | 0 | -12 | 245 | D | |||||||||||||||
5/20/26 21:22 | 5/20/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Pande Atul | NC | D | 1 | S.d | -192 | 32.00 | 0 | -6 | 137 | D | ||||||||||||||||
5/1/26 18:40 | 5/1/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Susman Robert Graham | NC | D | 1 | S | -68 | 27.17 | 0 | -3 | 36 | D | ||||||||||||||||
4/24/26 16:07 | 4/23/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Girao Tiago | NC | O | CFO | 1 | S | -763 | 29.62 | 0 | -26 | 248 | D | |||||||||||||||
4/24/26 16:05 | 4/23/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Stout Jay S | NC | O | CTO | 2 | S | -333 | 25.85 | 0 | -13 | 254 | D | |||||||||||||||
4/10/26 16:05 | 4/8/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Van Tuyl Christopher | NC | O | GC | 2 | S | -200 | 24.88 | 0 | -8 | 183 | D | |||||||||||||||
4/3/26 16:33 | 4/2/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Venker Eric | NC | DO | CEO | 1 | S.d | -343 | 24.10 | 0 | -14 | 20 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |